Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

2.

NPM1-Mutated AML: Not All Treatments Are Equal

3.

mRNA-based COVID vaccines generate improved responses to immunotherapy

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Telemedicine Not Reaching Rural Psychiatric Patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot